ADJUVANCE TECHNOLOGIES INC

formerly Adjuvance Technologies

Lincoln, United States · Founded 2017 · $23.0M raised

Headquarters
Lincoln, Nebraska
Employees
1–10
Founded
2017
Business Model
B2B
Total Funding
$23.0M
Last Round
$1.5M GrantMay 2020
Rounds
6

About

Adjuvance Technologies is a Lincoln, Nebraska biopharmaceutical company developing next-generation semi-synthetic saponin adjuvants to improve vaccine efficacy and duration. The company licenses its proprietary adjuvant platform to vaccine developers globally and has collaborated with Memorial Sloan-Kettering Cancer Center.

Summary

ADJUVANCE TECHNOLOGIES INC is a Biotech company based in Lincoln, United States, founded in 2017. It has raised $23.0M in total across 6 rounds, most recently a $1.5M Grant round in May 2020. Investors include National Institutes of Health, Morningside Group and 5Y Capital.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

GrantMay 2020
$1.5M

Sign up to see all 6 rounds

Seed through Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ADJUVANCE TECHNOLOGIES INC on Indexed.vc
<a href="https://indexed.vc/companies/adjuvance-technologies-inc"><img src="https://indexed.vc/api/badge/company/adjuvance-technologies-inc" alt="ADJUVANCE TECHNOLOGIES INC on Indexed.vc" width="260" height="76" /></a>